Hey there! Welcome!
Get updated on
Key Trials
Asthma_6
Asthma Symptom Control with Once-daily FF/VI 100/25 mcg versus Twice-daily B/F 160/4.5 mcg
The present study compared asthma symptom control in patients who initiated once-daily fluticasone furoate/vilanterol (FF/VI) 100/25 mcg and twice-daily B/F 160/4.5 mcg. The findings indicated that once-daily FF/VI 100/25 mcg was associated with better asthma control than twice-daily budesonide/formoterol (B/F) 160/4.5 mcg.

Spotlight

eCME Spotlight banner Final
PodCast
Conference Highlights
Patient education
Slide Library
Slide1
Giant Benign Prostatic Hyperplasia - A Case Report
BPH, a common condition in older men, can occasionally progress to giant prostatic hyperplasia, where the prostate gland exceeds 500 g. Surgical options may be considered for complications that are challenging to manage with medication. In this case study, the patient successfully underwent a transvesical prostatectomy to treat a significantly enlarged prostate weighing 600 g.
Resources

Resources

A wide range of informative monographs, booklets and newsletters; all developed in-house by Cipla.

View all
Research

Our Research

Snapshots of clinical research on molecules and diseases conducted by Cipla.

View all